Literature DB >> 28862435

A Luminescent 3d-4f-4d MOF Nanoprobe as a Diagnosis Platform for Human Occupational Exposure to Vinyl Chloride Carcinogen.

Ji-Na Hao1, Xiao-Yu Xu1, Xiao Lian1, Chi Zhang1, Bing Yan1.   

Abstract

A luminescent nanoprobe based on a lanthanide-transition heterometallic metal-organic framework (MOF) is first designed for specific detection of urinary thiodiglycolic acid (TDGA) which is the biomarker of carcinogenic vinyl chloride monomer (VCM) and represents the internal dose of human exposure to VCM. The nanoprobe demonstrates high selectivity to TDGA with about 27.5-fold luminescence enhancement. It also displays excellent sensitivity with a detection limit as low as 89 ng·mL-1 and fast response to TDGA within 4 min, while refraining from the interference of other coexisting species in urine. Such good sensing performance enables the nanoprobe to practically monitor TDGA levels in human urine. Moreover, a portable urine dipstick based on the sensor is developed to conveniently evaluate individuals' intoxication degree of VCM. This fast, sensitive, and selective nanoprobe has promising potential to be a useful tool for point-of-care diagnosis of disease associated with VCM exposure.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28862435     DOI: 10.1021/acs.inorgchem.7b01549

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  3 in total

1.  A Ratiometric Fluorescent Sensor Based on Dye/Tb (III) Functionalized UiO-66 for Highly Sensitive Detection of TDGA.

Authors:  Yangchun Fan; Xin Jiang; Jie Che; Mingfeng Li; Xuejuan Zhang; Daojiang Gao; Jian Bi; Zhanglei Ning
Journal:  Molecules       Date:  2022-10-03       Impact factor: 4.927

Review 2.  Luminescent Lanthanide MOFs: A Unique Platform for Chemical Sensing.

Authors:  Shu-Na Zhao; Guangbo Wang; Dirk Poelman; Pascal Van Der Voort
Journal:  Materials (Basel)       Date:  2018-04-07       Impact factor: 3.623

3.  Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.

Authors:  Xin Leng; Xiaoxv Dong; Wenping Wang; Na Sai; Chunjing Yang; Longtai You; Hongliang Huang; Xingbin Yin; Jian Ni
Journal:  Molecules       Date:  2018-09-28       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.